Mock James M
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Mock James M. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MRNA | Chief Financial Officer | Tax Withholding | 22,817 | $25.49 | $581,605 | Dec 5, 2025 |
| MRNA | Chief Financial Officer | Option Exercise | 329 | — | — | Nov 28, 2025 |
| MRNA | Chief Financial Officer | Option Exercise | 1,453 | — | — | Oct 3, 2025 |
| MRNA | Chief Financial Officer | Tax Withholding | 160 | $25.10 | $4,016 | Aug 27, 2025 |
| MRNA | Chief Financial Officer | Tax Withholding | 703 | $30.28 | $21,287 | Jul 3, 2025 |
| MRNA | Chief Financial Officer | Option Exercise | 328 | — | — | May 27, 2025 |
| MRNA | Chief Financial Officer | Tax Withholding | 703 | $25.73 | $18,088 | Apr 4, 2025 |
| MRNA | Chief Financial Officer | Tax Withholding | 160 | $31.09 | $4,974 | Feb 28, 2025 |
| MRNA | Chief Financial Officer | Tax Withholding | 642 | $33.58 | $21,558 | Feb 27, 2025 |
| MRNA | Chief Financial Officer | Tax Withholding | 780 | $42.00 | $32,760 | Jan 3, 2025 |
| MRNA | Chief Financial Officer | Sale | 1,420 | $42.79 | $60,762 | Nov 27, 2024 |
| MRNA | Chief Financial Officer | Option Exercise | 1,453 | — | — | Oct 7, 2024 |
| MRNA | Chief Financial Officer | Option Exercise | 329 | — | — | Aug 29, 2024 |
| MRNA | Chief Financial Officer | Option Exercise | 1,326 | — | — | Aug 27, 2024 |
| MRNA | Chief Financial Officer | Option Exercise | 1,452 | — | — | Jul 8, 2024 |
| MRNA | Chief Financial Officer | Sale | 691 | $140.72 | $97,238 | May 31, 2024 |
| MRNA | Chief Financial Officer | Option Exercise | 1,326 | — | — | May 28, 2024 |
| MRNA | Chief Financial Officer | Sale | 183 | $144.50 | $26,444 | May 28, 2024 |
| MRNA | Chief Financial Officer | Sale | 705 | $101.93 | $71,861 | Apr 5, 2024 |
| MRNA | Chief Financial Officer | Option Exercise | 1,315 | — | — | Feb 29, 2024 |
| MRNA | Chief Financial Officer | Sale | 772 | $109.75 | $84,727 | Jan 5, 2024 |
| MRNA | Chief Financial Officer | Sale | 2,858 | $102.50 | $292,945 | Oct 5, 2023 |
| RVTY | Please See Remarks | Sale | 2,290 | $145.78 | $333,836 | Jun 24, 2022 |
| RVTY | Please See Remarks | Award / Grant | 13,054 | — | — | Feb 4, 2022 |
| RVTY | Please See Remarks | Sale | 1,100 | $187.17 | $205,887 | Sep 20, 2021 |
| RVTY | Please See Remarks | Tax Withholding | 4,005 | $143.50 | $574,718 | May 17, 2021 |
| RVTY | Please See Remarks | Tax Withholding | 543 | $130.99 | $71,128 | Apr 6, 2021 |
| RVTY | Please See Remarks | Award / Grant | 2,678 | — | — | Feb 5, 2021 |
| RVTY | Please See Remarks | Tax Withholding | 1,774 | $147.07 | $260,902 | Feb 1, 2021 |
| RVTY | Please See Remarks | Sale | 100 | $125.08 | $12,508 | Oct 2, 2020 |
| RVTY | Please See Remarks | Tax Withholding | 2,950 | $91.97 | $271,312 | May 15, 2020 |
| RVTY | Please See Remarks | Award / Grant | 1,124 | $75.13 | $84,446 | Apr 6, 2020 |
| RVTY | Please See Remarks | Award / Grant | 3,620 | — | — | Jan 30, 2020 |
| RVTY | Please See Remarks | Tax Withholding | 3,406 | $89.04 | $303,270 | May 15, 2019 |
| RVTY | Please See Remarks | Award / Grant | 3,264 | — | — | Feb 5, 2019 |
| RVTY | Please See Remarks | Award / Grant | 27,089 | — | — | May 15, 2018 |